Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003754480 | SCV004436356 | likely benign | Kabuki syndrome | 2023-02-03 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004731558 | SCV005338664 | uncertain significance | KMT2D-related disorder | 2024-04-04 | no assertion criteria provided | clinical testing | The KMT2D c.2388T>G variant is predicted to result in the amino acid substitution p.His796Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0010% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |